[ExI] good bexarotene article

[spike]

>... On Behalf Of Jeff Davis
Subject: Re: [ExI] good bexarotene article

 

On Wed, Feb 15, 2012 at 4:28 PM, spike < <mailto:spike66 at att.net>
spike66 at att.net> wrote:

>> Ow, discouraging realization, it's been six days since the Scientific 

> American article came out.  Surely someone somewhere has done this 

> test by now.  If it worked in humans the way it does in mice, we would 

> likely have heard it by about Sunday afternoon... spike

 

>...Perhaps someone should give the news people a call, see what's keeping
them?

 

Jeff

 

_______________________________________________

 

 

Saturday's Wall Street Journal commented thus:

 

Targretin is generally used at the highest tolerated dose in cancer
patients, according to Keith Flaherty, a skin-cancer specialist at Harvard
Medical School. The dosage that might be needed to treat Alzheimer's is
unclear but is likely far lower, he said.

 

http://online.wsj.com/article/SB10001424052970204642604577215382600942356.ht
ml

 

This is good news indeed.  Targretin is known to be a mild drug for side
effects, and having Dr. Flaherty comment that the AD dosage is likely to be
far lower is a good thing.

 

I am still looking for the online comments by people who have tried this.
Apparently Targretin is not easy to find.

 

spike

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://lists.extropy.org/pipermail/extropy-chat/attachments/20120215/b2c55da2/attachment.html>